Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine
Clinical trial NCT05313035 · COMPLETED
Trial details
- NCT number
- NCT05313035
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2022-07-22
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.